Serotonin transporter gene polymorphisms: Relation with platelet serotonin level in patients with primary Sjogren's syndrome

Journal of Neuroimmunology

Volumn 282, Issue , 2015, Pages 104-109

  Markeljevic, J ^a   Sarac, H ^a,b   Bozina, N ^b   Henigsberg, N ^a   Simic, M ^c   Cicin Sain, L ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c INSTITUTE OF IMMUNOLOGY   (Croatia)

^d RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

5 HTTLPR rs25531; 5 HTTVNTRin2; Platelet serotonin; Serotonin transporter polymorphism; Sjogren syndrome

Indexed keywords

SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROATIAN (CITIZEN); FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SEROTONIN TRANSPORTER GENE; SJOEGREN SYNDROME; THROMBOCYTE; VARIABLE NUMBER OF TANDEM REPEAT; BLOOD; GENETICS; HAPLOTYPE; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SJOGREN'S SYNDROME; YOUNG ADULT;

EID: 84928565397     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.04.002     Document Type: Article

References (49)

1. Ahern G.P. 5-HT and the immune system. Curr. Opin. Pharmacol. 2011, 11(1):29-33. (Feb).
2. Bonvicini C., Minelli A., Scassellati C., Bortolomasi M., Segala M., Sartori R., Giacopuzzi M., Gennarelli M. Serotonin transporter gene polymorphisms and treatment-resistant depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 16(34(6)):934-939.
3. Bozina N., Mihaljević-Peles A., Sagud M., Jakovljević M., Sertic J. Serotonin transporter polymorphism in Croatian patients with major depressive disorder. Psychiatr. Danub. 2006, 18(1-2):83-89.
4. Bozina N., Medved V., Kuzman M.R., Sain I., Sertic J. Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients. J. Psychopharmacol. 2007, 21(7):728-734.
5. Brenner B., Harney J.T., Ahmed B.A., Jeffus B.C., Unal R., Mehta J.L., Kilic F. Plasma serotonin levels and the platelet serotonin transporter. J. Neurochem. 2007, 102:206-215.
6. Cloutier N., Paré A., Farndale R.W., Schumacher H.R., Nigrovic P.A., Lacroix S., Boilard E. Platelets can enhance vascular permeability. Blood 2012, 9(120(6)):1334-1343.
7. Coutinho A.M., Oliveira G., Morgadinho T., Fesel C., Macedo T.R., Bento C., Marques C., Ataíde A., Miguel T., Borges L., Vicent A.M. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol. Psychiatry 2004, 9(3):264-271.
8. Davies N.W., Guillemin G., Brew B.J. Tryptophan, neurodegeneration and HIV associated neurocognitive disorder. Int. J. Tryptophan Res. 2010, 3:121-140.
9. Emamian E.S., Leon J., Baechler E.C., Tobon L.M.M., Gaffney P.M., Huang A.J.W., Segal B., Rhodus N.L., Petri M., Gregersen P.K., Behrens T.V.W., Moser K.L. Comparison of gene expression profiles between patients with Sjogren's syndrome and systemic lupus erythematosus. ACR/ARHP Scientific Meeting 2006, 58. [abstract], Program Book.
10. Eskandari F., Webster J.I., Sternberg E.M. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res. Ther. 2003, 5(6):251-265.
11. Firk C., Markus C.R. Differential effects of 5-HTTLPR genotypes on mood, memory, and attention bias following acute tryptophan depletion and stress exposure. Psychopharmacology (Berl) 2009, 203(4):805-818.
12. Greenberg B.D., Tolliver T.J., Huang S.J., Li Q., Bengel D., Murphy D.L. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 1999, 5(88(1)):75-83. (88(1):83-7).
13. Gresele P. The platelet in asthma. The Platelet in Health and Disease 1991, 132-157. Blackwell Scientific Publications, Oxford. C.P. Page (Ed.).
14. Heils A., Teufel A., Petri S., Stöber G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996, 66(6):2621-2624.
15. Holsboer F. How can we realize the promise of personalized antidepressant medicines?. Nat. Rev. Neurosci. 2008, 9(8):638-646.
16. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 2006, 78(5):815-826.
17. Idzko M., Panther E., Stratz C., Muller T., Bayer H., Zissel G., Durk T., Sorichter S., Di Virgilio F., Geissler M., Fiebich B., Herouy Y., Elsner P., Norgauer J., Ferrari D. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J. Immunol. 2004, 172:6011-6019.
18. Ito K., Yoshida K., Sato K., Takahashi H., Kamata M., Higuchi H., Shimizu T., Ito K., Inoue K., Tezuka T., Suzuki T., Ohkubo T., Sugawara K., Otani K. A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine. Psychiatry Res. 2002, 111:235-239.
19. Jernej B., Banovic M., Cicin-Sain L., Hranilovic D., Balija M., Oreskovic D., Folnegovic-Smalc V. Physiological characteristics of platelet/circulatory serotonin: study on a large human population. Psychiatry Res. 2000, 94:153-162.
20. Juhasz G., Zsombok T., Laszik A., Gonda X., Sotonyi P., Faludi G., Bagdy G. Association analysis of 5-HTTLPR variants, 5-HT2a receptor gene 102T/C polymorphism and migraine. J Neurogenet 2003, 17(2-3):231-240.
21. Kishida I., Aklillu E., Kawanishi C., Bertilsson L., Agren H. Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression. Neuropsychopharmacology 2007, 32(10):2143-2151.
22. Kiyohara C., Yoshimasu K. Molecular epidemiology of major depressive disorder. Environ. Health Prev. Med. 2009, 14(2):71-87.
23. Klimiuk P.S., Grennan A., Weinkove C., Jayson M.I. Platelet serotonin in systemic sclerosis. Ann. Rheum. Dis. 1989, 48(7):586-589.
24. Lesch K.P., Wolozin B.L., Murphy D.L., Riederer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J. Neurochem. 1993, 60:2319-2322.
25. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Müller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
26. MacKenzie A., Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(26):15251-15255.
27. Martin J., Cleak J., Willis-Owen S.A., Flint J., Shifman S. Mapping regulatory variants for the serotonin transporter gene based on allelic expression imbalance. Mol. Psychiatry 2007, 12:421-422.
28. Mercado C.P., Killic F. Molecular mechanism of SERT in platelets: regulation of plasma serotonin levels. Mole Interv. 2010, 10(4):231-241.
29. Meyerhoff J., Dorsch C.A. Decreased platelet serotonin levels in systemic lupus erythematosus. Arthritis Rheum. 1981, 24:1495-1500.
30. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16(3):1215.
31. Mrazek D.A., Rush A.J., Biernacka J.M., O'Kane D.J., Cunningham J.M., Wieben E.D., Schaid D.J., Drews M.S., Courson V.L., Snyder K.A., Black J.L., Weinshilboum R.M. SLC6A4 variation and citalopram response. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 2009.
32. Nakamura M., Ueno S., Sano A., Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry 2000, 5(1):32-38.
33. Patrick R.P., Ames B.N. Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J. 2014, 28(6):2398-2413.
34. Pivac N., Nedić G., Mustapić M., Babić A., Stipčević T., Borovečki F., Hajnšek S., Mück-Šeler D. The lack of genotype-phenotype relationship between platelet serotonin concentration and serotonin transporter gene promoter polymorphism in healthy subjects. Neurosci. Lett. 2009, 462(1).
35. Ramamoorthy S., Blakely R.D. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 1999, 285(5428):763-766.
36. Rammamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., Ganapathy V., Blakely R.D. Antidepressant-and-cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:2542-2546.
37. Rauch J.L., Johnson M.E., Fei Y.J., Li J.Q., Shendarkar N., Hobby H.M., Ganapathy V., Leibach F.H. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol. Psychiatry 2002, 51:723-732.
38. Roiser J.P., Blackwell A.D., Cools R., Clark L., Rubinstein D.C., Robbins T.W., Sahakian B.J. Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology 2006, 31(10):2264-2272.
39. Sarac H., Markeljevic J., Mokrovic G., Erdeljic V., Bozina N., Cicin-Sain L. Platelet serotonin in primary Sjogren's syndrome: level and relation with disease activity. J. Neuroimmunol. 2012, 15(251(1-2)):87-89.
40. Šarac H., Markeljević J., Erdeljić V., Josipović-Jelić Z., Hajnšek S., Klapan T., Batinica M., Baršić I., Sertic J., Dobrila Dintinjana R. Signal hyperintensities on brain magnetic resonance imaging in patients with primary Sjogren syndrome and frequent episodic tension-type headache: relation to platelet serotonin level and disease activity. J. Rheumatol. 2013, 40(8):1360-1366.
41. Sellam J., Proulle V., Jüngel A., Ittah M., Miceli Richard C., Gottenberg J.E., Toti F., Benessiano J., Gay S., Freyssinet J.M., Mariette X. Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res. Ther. 2009, 11:R156.
42. Smits K.M., Smits L.J., Schouten J.S., Stelma F.F., Nelemans P., Prins M.H. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol. Psychiatry 2004, 9(5):433-441.
43. Sookoian S., Gemma C., Garcia S.I., Gianotti T.F., Dieuzeide G., Roussos A., Tonietti M., Trifone L., Kanevsky D., Gonzalez C.D., et al. Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity 2007, 15:271-276.
44. Stoltenberg S.F., Twitchell G.R., Hanna G.L., Cook E.H., Fitzgerald H.E., Zucker R.A., Little K.Y. Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. Am. J. Med. Genet. 2002, 8(114(2)):230-234.
45. Totani L., Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler. Thromb. Vasc. Biol. 2010, 30(12):2357-2361.
46. Valtýsdótir S.T., Wide L., Hällgren R. Low serum dehydroepiandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function. J. Rheumatol. 2001, 28:1259-1265.
47. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., Daniels T.E., Fox P.C., Fox R.I., Kassan S.S., Pillemer S.R., Talal N., Weisman M.H. European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002, 61:554-558.
48. Wildenberg M.E., van Helden-Meeuwsen C.G., van de Merwe J.P., Drexhage H.A., Versnel M.A. Systemic increase in type I interferon activity in Sjogren's syndrome: a putative role for plasmacytoid dendritic cells. Eur. J. Immunol. 2008, 38:2024-2033.
49. Zeller J., Weissbarth E., Baruth B., Mielke H., Deicher H. Serotonin content of platelets in inflammatory rheumatic diseases. Arthritis Rheum. 1983, 26:532-540.